Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter

Your Filters

Subject : antibodies, viral Subject : covid-19 Subject : emotional engagement Subject : immunization, secondary
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer.

  • Authors : Zeng C; Center for Retrovirus Research, Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, Ohio State University, Columbus, OH 43210, USA.

Subjects: Immunization, Secondary*; 2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/*immunology ; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology COVID-19 breakthrough infectionsSARS-CoV-2 variants

  • Source: Cancer cell [Cancer Cell] 2022 Feb 14; Vol. 40 (2), pp. 117-119. Date of Electronic Publication: 2021 Dec 30.Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2021 Dec 02; Vol. 17 (12), pp. e1010022. Date of Electronic Publication: 2021 Dec 02 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients.

  • Authors : Azzi L; Azienda Socio-Sanitaria Territoriale dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Varese, Italy. Electronic address: .; Dalla Gasperina D

Subjects: Immunization, Secondary*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology

  • Source: EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103788. Date of Electronic Publication: 2021 Dec 23.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response.

  • Authors : Reimann P; Department of Internal Medicine II, Feldkirch Academic Teaching Hospital, Feldkirch, Austria.; Private University of the Principality of Liechtenstein, Triesen, Principality of Liechtenstein.

Subjects: COVID-19*/COVID-19*/COVID-19*/blood ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Immunization, Secondary*

  • Source: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (3), pp. 577-584. Date of Electronic Publication: 2021 Dec 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges.

  • Authors : Faro-Viana J; CHLO, Centro Hospitalar de Lisboa Ocidental, Serviço de Patologia Clínica, Lisbon, 1449-005, Portugal.; Bergman ML

Subjects: Immunization, Secondary*; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology

  • Source: Nature communications [Nat Commun] 2022 Jan 10; Vol. 13 (1), pp. 140. Date of Electronic Publication: 2022 Jan 10.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Establishment of human post-vaccination SARS-CoV-2 standard reference sera.

  • Authors : Xiang J; Iowa City Veterans Administration Healthcare System, 601 Highway 6, Iowa City, IA 52246, USA; The University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology SARS-CoV-2 variants

  • Source: Journal of immunological methods [J Immunol Methods] 2024 Jul; Vol. 530, pp. 113698. Date of Electronic Publication: 2024 May 31.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1305440 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Response to COVID-19 vaccination in patients on cancer therapy: Analysis in a SARS-CoV-2-naïve population.

  • Authors : Cavic G; Research School of Biology, Australian National University, Canberra, Australia.; Almonte AA

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/immunology

  • Source: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2024 Jun; Vol. 20 (3), pp. 379-385. Date of Electronic Publication: 2024 Jan 14.Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101241430 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children <5 Years of Age.

  • Authors : Dalapati T; Medical Scientist Training Program.; Department of Molecular Genetics and Microbiology.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; 2019-nCoV Vaccine mRNA-1273*/2019-nCoV Vaccine mRNA-1273*/2019-nCoV Vaccine mRNA-1273*/immunology

  • Source: Pediatrics [Pediatrics] 2024 Jun 01; Vol. 153 (6).Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Homologous and Heterologous Covid-19 Booster Vaccinations Against SARS-CoV-2 Infection in the Elderly.

  • Authors : Acer Ö; Department of Medical Microbiology, Medical Faculty, Siirt University, 56100, Siirt, Türkiye. .; Genç Bahçe Y

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology SARS-CoV-2 variants

  • Source: Current microbiology [Curr Microbiol] 2024 May 13; Vol. 81 (7), pp. 171. Date of Electronic Publication: 2024 May 13.Publisher: Springer International Country of Publication: United States NLM ID: 7808448 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies.

  • Authors : Lu X; Laboratory of Molecular Immunology, Immunology Frontier Research Center, Osaka University, Suita, Japan.; Hayashi H

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/immunology

  • Source: ELife [Elife] 2024 May 08; Vol. 12. Date of Electronic Publication: 2024 May 08.Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×